Diagnosis of multiple system atrophy
- PMID: 29111419
- PMCID: PMC5869112
- DOI: 10.1016/j.autneu.2017.10.007
Diagnosis of multiple system atrophy
Abstract
Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders, particularly in the early stages of the disease. An autonomic-only presentation can be indistinguishable from pure autonomic failure. Patients presenting with parkinsonism may be misdiagnosed as having Parkinson disease. Patients presenting with the cerebellar phenotype of MSA can mimic other adult-onset ataxias due to alcohol, chemotherapeutic agents, lead, lithium, and toluene, or vitamin E deficiency, as well as paraneoplastic, autoimmune, or genetic ataxias. A careful medical history and meticulous neurological examination remain the cornerstone for the accurate diagnosis of MSA. Ancillary investigations are helpful to support the diagnosis, rule out potential mimics, and define therapeutic strategies. This review summarizes diagnostic investigations useful in the differential diagnosis of patients with suspected MSA. Currently used techniques include structural and functional brain imaging, cardiac sympathetic imaging, cardiovascular autonomic testing, olfactory testing, sleep study, urological evaluation, and dysphagia and cognitive assessments. Despite advances in the diagnostic tools for MSA in recent years and the availability of consensus criteria for clinical diagnosis, the diagnostic accuracy of MSA remains sub-optimal. As other diagnostic tools emerge, including skin biopsy, retinal biomarkers, blood and cerebrospinal fluid biomarkers, and advanced genetic testing, a more accurate and earlier recognition of MSA should be possible, even in the prodromal stages. This has important implications as misdiagnosis can result in inappropriate treatment, patient and family distress, and erroneous eligibility for clinical trials of disease-modifying drugs.
Keywords: Autonomic testing; Biomarkers; Diagnosis; Multiple system atrophy; Neuroimaging; Orthostatic hypotension.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures


References
-
- Anderson T, Luxon L, Quinn N, Daniel S, David Marsden C, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Movement disorders : official journal of the Movement Disorder Society. 2008;23:977–984. - PubMed
-
- Arbizu J, Luquin MR, Abella J, de la Fuente-Fernandez R, Fernandez-Torron R, Garcia-Solis D, Garrastachu P, Jimenez-Hoyuela JM, Llaneza M, Lomena F, Lorenzo-Bosquet C, Marti MJ, Martinez-Castrillo JC, Mir P, Mitjavila M, Ruiz-Martinez J, Vela L. Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use. Rev Esp Med Nucl Imagen Mol. 2014;33:215–226. - PubMed
-
- Asahina M, Low DA, Mathias CJ, Fujinuma Y, Katagiri A, Yamanaka Y, Shimada J, Poudel A, Kuwabara S. Skin temperature of the hand in multiple system atrophy and Parkinson’s disease. Parkinsonism & related disorders. 2013;19:560–562. - PubMed
-
- Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805–821. - PubMed
-
- Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson’s disease. Lancet neurology. 2005;4:423–431. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials